Eldec Pharmaceuticals
Chapel Hill, US · Delaware corporation · 1 known investors
Find your way into Eldec Pharmaceuticals
Each arrow is one introduction. Sign up to fill in the first one.
Ask Fen Zhao to introduce you to Saira Ahmad
You →Fen · together at National Science Foundation →Saira
Ask Jamie Chen to introduce you to Robert Tarran
You →Jamie · together at University of North Carolina at Chapel Hill →Robert
Sign up to find every way you can get introduced to Eldec Pharmaceuticals
- Your email: who you already know at Eldec Pharmaceuticals, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Eldec Pharmaceuticals team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Eldec is a biotechnology company developing peptide-based therapeutics targeting SPLUNC1's modulation of Orai1 activity, with lead programs ELD615 and ELD607 for lung diseases such as cystic fibrosis and non-CF bronchiectasis. Its research programs are supported by NHLBI, NIAID, NIDDK, and the North Carolina Biotechnology Center.
Founders & leadership

Investors · 1
Reported raises · per SEC filings
Form D private placements$200K disclosed across 1 round · 2026
▶$200KraisedFeb 2026 · 1 investors · PharmaceuticalsRule 506(b)
- Robert TarranExecutive Officer, Director
- Robert SchotzingerExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $200K
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Eldec Pharmaceuticals.
In the news
Frequently asked questions
- What does Eldec Pharmaceuticals do?
- Eldec is a biotechnology company developing peptide-based therapeutics targeting SPLUNC1's modulation of Orai1 activity, with lead programs ELD615 and ELD607 for lung diseases such as cystic fibrosis and non-CF bronchiectasis. Its research programs are supported by NHLBI, NIAID, NIDDK, and the North Carolina Biotechnology Center.
- Who founded Eldec Pharmaceuticals?
- Eldec Pharmaceuticals was founded by Robert Tarran, Saira Ahmad, Flori Sassano.
- Who are Eldec Pharmaceuticals's investors?
- Eldec Pharmaceuticals's investors include Cape Fear BioCapital.
- How much funding has Eldec Pharmaceuticals raised?
- Eldec Pharmaceuticals has disclosed $200K raised across 1 round.
- Where is Eldec Pharmaceuticals headquartered?
- Eldec Pharmaceuticals is headquartered in Chapel Hill, US.

